Product Information

METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1190 per EA under NDC 43547048610. Its NADAC has been published 283 times since Jun 23, 2021.

FDA first approved this application on Jul 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 5 MG TABLET

Methylphenidate hydrochloride
$0.1190per EA
DEA Schedule CII

Strength

5 mg/1

NDC

43547048610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212697

FDA Approved

7/23/2020

TE Code

AB

On Market Since

7/1/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 283 times since Jun 23, 2021, and over the history we have for it it has risen 12.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1190 per EA
All-time high$0.1434 (Feb 11, 2026)
All-time low$0.0841 (Jul 17, 2024)
52-week high$0.1434
52-week low$0.1190
Median price$0.1138
Average price$0.1166
Largest weekly change+55.5% (Aug 21, 2024)
Weeks tracked283
Tracking sinceJun 23, 2021

Price History

1W

-2.3%

1M

-6.2%

3M

-9.1%

6M

-12.3%

1Y

-12.6%

3Y

+7.5%

5Y

+10.1%

All

+12.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methylphenidate hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1190 per EA (NDC 43547048610), effective Nov 18, 2026.

How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has risen 12.3%. It has been tracked across 283 weekly CMS publications since Jun 23, 2021.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?

Since Jun 23, 2021, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.0841 (Jul 17, 2024) to a high of $0.1434 (Feb 11, 2026), with a median of $0.1138 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of METHYLPHENIDATE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METHYLPHENIDATE 5 MG TABLET?

METHYLPHENIDATE 5 MG TABLET (NDC 43547048610) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.